| 2.07 0.06 (2.99%) | 10-17 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 1-year : | ||
| Resists | First : | Second : | ||
| Pivot price | ||||
| Supports | First : | Second : | ||
| MAs | MA(5) : | MA(20) : | ||
| MA(100) : | MA(250) : | |||
| MACD | MACD : | Signal : | ||
| %K %D | K(14,3) : | D(3) : | ||
| RSI | RSI(14): | |||
| 52-week | High : | Low : | ||
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
eMagin Corporation is a specialized firm dedicated to the research, production, and global distribution of compact organic light-emitting diode (OLED) microdisplays, which are fabricated on silicon substrates. Beyond these miniature screens, the company also develops virtual imaging solutions that integrate their core OLED microdisplay technology, along with various associated components. Their product catalog features a diverse portfolio of high-resolution OLED microdisplays, encompassing formats such as Super Video Graphics Array (SVGA)+, digital SVGA OLED-XL, Super Extended Graphics Array (SXGA) OLED-XL/XLS, Video Graphics Array (VGA) OLED-XL, and Widescreen Ultra-Extended Graphics Array (WUXGA) OLED-XL. To support original equipment manufacturers (OEMs), eMagin additionally provides design reference kits, which bundle a microdisplay with the necessary electronics for evaluation purposes. They also offer near-eye virtual imaging modules, cleverly combining their OLED-on-silicon microdisplays with specialized lenses and electronic interfaces, ready for integration into OEM products. Further enhancing their offerings are prism optics – molded plastic lenses designed to deliver realistic, eye-fatigue-reducing images from their AMOLED microdisplays – and essential driver boards. These advanced microdisplays and imaging solutions serve as critical components in a wide array of demanding applications. This includes military aviation helmets, advanced weapon sights and targeting systems, night vision and thermal imaging devices, sophisticated training and simulation platforms, visualization tools for ocular surgery, portable ultrasound units, and cutting-edge augmented reality systems. The company's origins trace back to 1996, and its headquarters are situated in Hopewell Junction, New York.
Wed, 17 Jul 2024
Hot Penny Stocks in Tech: Top Picks for 2024 - StocksToTrade
Wed, 18 Oct 2023
Samsung Display Completes Acquisition of eMagin - citybiz
Wed, 04 Jan 2023
Trading Breakouts: Riding the Hype in This Insane Market - www.timothysykes.com
Sat, 09 Jul 2022
Best Cheap Tech Stocks Under $5 - Benzinga
Wed, 20 Jan 2021
Thinking about buying stock in Dare Bioscience, Endra Life Sciences, Lineage Cell Therapeutics, Inuvo Inc, or eMagin Corp? - Lelezard
Thu, 13 Aug 2020
eMagin's dPd(TM) Technology Reinforces OLED Microdisplay Industry Leadership - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
AMEX
|
|
|
Sector:
Technology
|
|
|
Industry:
Hardware, Equipment & Parts
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | (%) |
| Held by Institutions | (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | |
| EPS Est Next Qtrly | |
| EPS Est This Year | |
| EPS Est Next Year | |
| Book Value (p.s.) | |
| Profit Margin | % |
| Operating Margin | % |
| Return on Assets (ttm) | % |
| Return on Equity (ttm) | % |
| Qtrly Rev. Growth | % |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | |
| Price to Cash Flow |
| Dividend | |
| Forward Dividend | |
| Dividend Yield | 0% |
| Dividend Pay Date | |
| Ex-Dividend Date |
|
|
|
|
|
|
|
|
|